Clinical trials
Phase 2 Prostatic Neoplasms trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 5 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 5 |
| 2016 | 2 |
| 2017 | 6 |
| 2018 | 6 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
| Terminated | 11 |
| Active, not recruiting | 5 |
| Recruiting | 4 |
| Unknown status | 3 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 4 |
| Astellas Pharma Inc | 3 |
| AstraZeneca | 3 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| Novartis Pharmaceuticals | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Astellas Pharma Global Development, Inc. | 2 |
| Bayer | 2 |
| Centre Georges Francois Leclerc | 2 |
| Centre Oscar Lambret | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 67 |
| Neoplasms | 6 |
| Genital Neoplasms, Male | 3 |
| Neoplasms by Site | 3 |
| Prostatic Diseases | 3 |
| Urogenital Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Carcinoma | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Colorectal Neoplasms | 2 |
Trials
Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.